CANDO CANCER (EIN 455315972) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2012

Legal Domicile

Phone

5153222333

Tax Period

2023-01-01 to 2023-12-31

CANDO CANCER, founded in 2012, is a small nonprofit in the Health Care sector that reported $408K in total revenue in fiscal year 2023. Revenue surged 32% from the prior year, signaling strong growth momentum. The organization ran a surplus of $163K, a strong 40% operating margin.

Mission

THE PURPOSE OF CANDO CANCER IS TO PROVIDE SUPPORT TO BREAST CANCER PATIENTS AND THEIR FAMILIES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $290,729

Program Service Revenue $0

Investment Income $10,446

Other Revenue $106,360

TOTAL REVENUE $407,535

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $23,718

Program Expenses $192,079

Other Expenses $52,763

TOTAL EXPENSES $244,842

Year-over-Year Comparison

	2023	2022	Change
Revenue	$407,535	$307,889	+0.3%
Expenses	$244,842	$266,232	-0.1%
Net Income	$162,693	$41,657	+2.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$35,505

Total Directors

$37,748

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MOLLY ZAVER	PRESIDENT	1.00	Officer Director	$1,094	$0	$1,094
HEATHER BREWER	VICE PRESIDENT	3.00	Officer Director	$2,526	$0	$2,526
KARI GILBERT	TREASURER	17.00	Officer Director	$6,456	$0	$6,456
DEONNE WINKEL	SECRETARY & PROGRAM DIRECT	55.00	Officer Director	$25,429	$0	$25,429
SUSAN BROWN	BOARD MEMBER	2.00	Director	$581	$0	$581
DAYNA BOYLES-CARPENTER	BOARD MEMBER	2.00	Director	$1,662	$0	$1,662
DANIEL KOLLMORGEN MD	BOARD MEMBER	2.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$407,535	$244,842	$535,525	$162,693
2022	$307,889	$266,232	$361,766	$41,657
2021	$312,755	$178,748	$363,025	$134,007

CANDO CANCER